Tissue Repair Company Report issue

For profit Phase 2
Founded: San Diego CA United States (2006)
Status: Acquired by Gene Biotherapeutics, Inc. (2006)

Organization Overview

First Clinical Trial
2006
NCT00065663
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Tissue Repair Company, 6740 Top Gun St, San Diego, CA 92121 USA, 858-259-4511

Active Ingredients

Drugs in Phase 2 Trials (1)

gam501 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 2)

Foot Ulcer (Phase 1)

Wounds and Injuries (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1